00:00:00
Speaker 1: Hello, welcome to The Upside with Jordan, a dose of good news because it's a big world out there. For those with a diagnosis of Parkinson's disease, and that's over a million Americans, including yours truly, billions of dollars in medical research has paved the way for exciting new therapies. One of the most promising is the emerging role of Tevapidon, considered a novel dopamine partial agonist. Expecting news on FDA approval this month. And if approved, the once-daily oral medication will be the first to selectively and partially activate D1 through D5 dopamine receptors. Don't have the time to go into the science, of course, here, but across three pivotal Phase III trials, Tevapidon showed true clinical benefit. One medical researcher said, We have not seen a Parkinson's drug with such a broad spectrum of use from early to advanced disease in decades. If you or someone you know has Parkinson's disease, ask your neurologist or motor disorder specialist about Tevapidon. Certainly worth bringing up. And that's The Upside with Jordan WBZ, Boston's news radio.
Speaker 1: Hello, welcome to The Upside with Jordan, a dose of good news because it's a big world out there. For those with a diagnosis of Parkinson's disease, and that's over a million Americans, including yours truly, billions of dollars in medical research has paved the way for exciting new therapies. One of the most promising is the emerging role of Tevapidon, considered a novel dopamine partial agonist. Expecting news on FDA approval this month. And if approved, the once-daily oral medication will be the first to selectively and partially activate D1 through D5 dopamine receptors. Don't have the time to go into the science, of course, here, but across three pivotal Phase III trials, Tevapidon showed true clinical benefit. One medical researcher said, We have not seen a Parkinson's drug with such a broad spectrum of use from early to advanced disease in decades. If you or someone you know has Parkinson's disease, ask your neurologist or motor disorder specialist about Tevapidon. Certainly worth bringing up. And that's The Upside with Jordan WBZ, Boston's news radio.
